Policy dialogue in Kyrgyzstan addresses imminent regulation of health technologies

On 28 February 2017, the WHO country office in Kyrgyzstan held a policy dialogue on new laws currently under discussion to regulate the pricing and procurement of medicines and health technologies in the country.

Minister of Health Dr Talantbek Batyraliev chaired the meeting, which gathered stakeholders representing the pharmaceutical industry, patients, prescribers, authorities and parliamentarians. Participants adopted a formal statement summarizing the discussions, and stressed the importance of having the laws adopted as soon as possible.

WHO/Europe and the WHO country office in Kyrgyzstan are supporting the Kyrgyz Ministry of Health in the development of the new health technology regulatory framework. The current law needs to be updated for harmonization with requirements of Eurasian Economic Union accession. The 3 draft laws under discussion deal with medicines, medical devices and transversal legal changes, and were developed by a multidisciplinary working group under the authority of the Government.

The passing of these laws is a turning point for the strengthening of the health care sector in Kyrgyzstan. The availability and affordability of good-quality medicines is a pillar of universal health coverage and will have positive consequences for the Kyrgyz population: registration and monitoring of medicines and medical devices will be strengthened; quality and circulation of health products will be better regulated; control and inspection activities will be improved, contributing to the elimination of smuggling and falsified and counterfeit medicines; and the pharmaceutical sector will be more transparent, predictable and accountable.

WHO/Europe will continue to support the Ministry of Health to ensure rapid and smooth adoption of the laws. The working group also plans to develop an aide-memoire for members of parliament to explain the changes in current legislation and the rationale behind them.

These activities are part of WHO/Europe’s support to Member States through its biennial collaborative agreement for 2016–2017 with the Ministry of Health of Kyrgyzstan.